Amneal Reports Third Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
Amneal Pharmaceuticals (AMRX) Tops Q3 EPS by 1c
November 3, 2021 6:02 AM EDTAmneal Pharmaceuticals (: AMRX) reported Q3 EPS of $0.21, $0.01 better than the analyst estimate of $0.20. Revenue for the quarter came in at $529 million versus the consensus estimate of $544.49 million.
GUIDANCE:
Amneal Pharmaceuticals sees FY2021 EPS of $0.78-$0.88, versus the consensus of $0.88. Amneal... More
